Raja M. Flores, MD

Raja M. Flores, MD

1440 Madison Avenue
New York, NY 10029

Tel: 212-241-9466
Fax: 212-659-1521

Thoracic Surgery

Thoracic Surgery
American Board of Surgery

Clinical Focus
Bronchoscopy, Diagnostic
Esophageal Cancer
Lung Cancer
Pleural Mesothelioma
Pulmonary Lobectomy
Robot-Assisted Thoracic Procedures
Upper GI Endoscopy
Video-Assisted Thoracic Surgery

MD, Albert Einstein College of Medicine

MS, Columbia University

BA, New York University

Residency, Surgery
Columbia-Presbyterian Medical Center

Residency, Cardiothoracic Surg
Brigham and Women's Hospital

Dr. Raja M. Flores is the Chief of the Division of Thoracic Surgery, Ames Professor of Cardiothoracic Surgery at The Mount Sinai Medical Center.

Dr. Flores’ is a recognized leader in the field of Thoracic Surgery for his pioneering efforts in the treatment of mesothelioma. He has established VATS lobectomy, a minimally invasive approach using three small incisions, as the gold standard in the surgical treatment of lung cancer.  He published two sentinel studies validating its oncological effectiveness by demonstrating equivalent survival and recurrence rates with fewer complications and shorter hospital stays when compared to standard thoracotomy.  Dr. Flores implemented the current program for this procedure at Memorial Sloan-Kettering Cancer Center. He was a lead investigator in a multicenter trial of neoadjuvant alimta/cisplatin, extrapleural pneumonectomy, and high-dose radiation which is designed to improve outcomes.

Dr. Flores currently has one of the largest VATS lobectomy experiences in the world. He is in the process of publishing, and has presented this data at the 90th Annual Meeting of the American Association for Thoracic Surgery.

Dr. Flores’ additional research interests are based on numerous past projects relating to the multimodality management of malignant pleural mesothelioma, as well as innovative surgical techniques in minimally invasive thoracic surgery for lung cancer. He has led a number of major studies, including clinical trials of neoadjuvant gemcitabine and cisplatin followed by extrapleural pneumonectomy and high dose radiation.

After earning an undergraduate degree in biochemistry from New York University, Dr. Flores attended the Albert Einstein College of Medicine, receiving his Medical Degree in 1992. He then spent five years at Columbia-Presbyterian Medical Center pursuing his General Surgery Internship and General Surgery Residency. He then completed a Thoracic Oncology Clinical Research Fellowship at Brigham and Women’s Hospital/Dana Faber Cancer Institute/CALGB in Boston, and his Cardiothoracic Surgery Residency at Brigham and Women’s Hospital, Harvard Medical School. He also received a Masters in Biostatistics from Columbia University.  Dr. Flores is a member of numerous medical and surgical societies and serves on several editorial boards.

Industry Relationships
Physicians and scientists on the faculty of Mount Sinai School of Medicine often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Flores did not report having any of the following types of financial relationships with industry during 2011 and/or 2012: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://www.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

CME Courses

No active CME courses for this presenter.